236 related articles for article (PubMed ID: 30027448)
1. Clinicopathological features of considerable reduction in androgen receptor expression in sebaceous gland carcinoma of the eyelid.
Yunoki T; Miyakoshi A; Otsuka M; Hayashi A
Int Ophthalmol; 2019 Aug; 39(8):1703-1708. PubMed ID: 30027448
[TBL] [Abstract][Full Text] [Related]
2. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.
Schmitz EJ; Herwig-Carl MC; Holz FG; Loeffler KU
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2277-2285. PubMed ID: 28741159
[TBL] [Abstract][Full Text] [Related]
3. Periocular sebaceous gland carcinoma: do androgen receptor (NR3C4) and nuclear survivin (BIRC5) have a prognostic significance?
Mulay K; Shah SJ; Aggarwal E; White VA; Honavar SG
Acta Ophthalmol; 2014 Dec; 92(8):e681-7. PubMed ID: 24930483
[TBL] [Abstract][Full Text] [Related]
4. ZEB2/SIP1 as novel prognostic indicator in eyelid sebaceous gland carcinoma.
Bhardwaj M; Sen S; Sharma A; Kashyap S; Chosdol K; Pushker N; Bajaj MS; Bakhshi S
Hum Pathol; 2015 Oct; 46(10):1437-42. PubMed ID: 26220160
[TBL] [Abstract][Full Text] [Related]
5. CDKN2A, CDK1, and CCNE1 overexpression in sebaceous gland carcinoma of eyelid.
Yunoki T; Hirano T; Tabuchi Y; Furusawa Y; Torigoe M; Nakajima T; Imura J; Hayashi A
Int Ophthalmol; 2020 Feb; 40(2):343-350. PubMed ID: 31571090
[TBL] [Abstract][Full Text] [Related]
6. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of cyclooxygenase 2 and peroxisome proliferator-activated receptor γ in eyelid sebaceous gland carcinoma.
Jayaraj P; Sen S; Bhattacharya T; Arora J; Yadav S; Chhoker V; Kumar A; Dhanaraj PS; Yadavilli KS; Verma M
Histopathology; 2016 Aug; 69(2):268-75. PubMed ID: 26791964
[TBL] [Abstract][Full Text] [Related]
8. Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target.
Lee MJ; Kim N; Choung HK; Choe JY; Khwarg SI; Kim JE
J Cancer Res Clin Oncol; 2016 Jan; 142(1):125-33. PubMed ID: 26141290
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor identification in the diagnosis of eyelid sebaceous carcinomas.
Jakobiec FA; Werdich X
Am J Ophthalmol; 2014 Mar; 157(3):687-96.e1-2. PubMed ID: 24333189
[TBL] [Abstract][Full Text] [Related]
10. Expression of retinoic acid-binding proteins and retinoic acid receptors in sebaceous cell carcinoma of the eyelids.
Tsai YJ; Wu SY; Huang HY; Ma DH; Wang NK; Hsiao CH; Cheng CY; Yeh LK
BMC Ophthalmol; 2015 Oct; 15():142. PubMed ID: 26503156
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin and β-catenin expression in sebaceous eyelid adenocarcinomas.
Li L; Zhang Z; Li B; Gao F; Li L; Jonas JB
Graefes Arch Clin Exp Ophthalmol; 2011 Dec; 249(12):1867-73. PubMed ID: 21739269
[TBL] [Abstract][Full Text] [Related]
12. Sebaceoma of the eyelid: a rare entity.
Mittal R; Tripathy D
Can J Ophthalmol; 2014 Jun; 49(3):e78-80. PubMed ID: 24862791
[No Abstract] [Full Text] [Related]
13. Vimentin overexpression as a novel poor prognostic biomarker in eyelid sebaceous gland carcinoma.
Bhardwaj M; Sen S; Chosdol K; Bakhshi S; Pushker N; Sharma A; Kashyap S; Bajaj MS; Singh VK
Br J Ophthalmol; 2020 Jun; 104(6):879-884. PubMed ID: 30940620
[TBL] [Abstract][Full Text] [Related]
14. Programmed death receptor Ligand 1 expression in eyelid sebaceous carcinoma: a consecutive case series of 41 patients.
Xu S; Yu H; Fu G; Fan X; Jia R
Acta Ophthalmol; 2019 May; 97(3):e390-e396. PubMed ID: 29862664
[TBL] [Abstract][Full Text] [Related]
15. Retinoid receptor subtypes in sebaceous cell carcinoma of the eyelid.
Chakravarti N; Saadati HG; El-Naggar AK; Lotan R; Diba RE; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2005 Jul; 21(4):292-7. PubMed ID: 16052143
[TBL] [Abstract][Full Text] [Related]
16. Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin.
Jakobiec FA; Mendoza PR
Am J Ophthalmol; 2014 Jan; 157(1):186-208.e2. PubMed ID: 24112633
[TBL] [Abstract][Full Text] [Related]
17. Correlation of the expression of telomerase RNA with risk factors for recurrence of sebaceous gland carcinoma.
Li B; Li N; Cheng G; Sun X; Xu X; Shi J; Li L; Chen C
Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):480-4. PubMed ID: 16133023
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of immune checkpoints in the tumour-stromal microenvironment of sebaceous gland carcinoma.
Singh L; Singh MK; Rizvi MA; Pushker N; Bakhshi S; Sen S; Kashyap S
Br J Ophthalmol; 2021 Jan; 105(1):48-56. PubMed ID: 32277010
[TBL] [Abstract][Full Text] [Related]
19. Ocular sebaceous gland carcinoma: an update of the literature.
Cicinelli MV; Kaliki S
Int Ophthalmol; 2019 May; 39(5):1187-1197. PubMed ID: 29696467
[TBL] [Abstract][Full Text] [Related]
20. Eyelid sebaceous gland carcinoma, validation of AJCC 8th edition T staging- a retrospective study from North India.
Sen S; Bhardwaj M; Jayaraj P; Bakhshi S; Pushker N; Kashyap S; Bajaj MS; Khandpur S
Acta Ophthalmol; 2023 Feb; 101(1):49-56. PubMed ID: 35751173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
